Pathology Research and Practice

Papers
(The H4-Index of Pathology Research and Practice is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-1995
Pathologic features of COVID-19: A concise review72
High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features63
The role of miRNAs in liver diseases: Potential therapeutic and clinical applications60
The future of pathology is digital58
A study of miRNAs as cornerstone in lung cancer pathogenesis and therapeutic resistance: A focus on signaling pathways interplay56
Hydroxycitric acid reverses tamoxifen resistance through inhibition of ATP citrate lyase55
miRNAs inspirations in hepatocellular carcinoma: Detrimental and favorable aspects of key performers53
miRNAs role in bladder cancer pathogenesis and targeted therapy: Signaling pathways interplay – A review51
Cancer immunotherapy: Challenges and limitations50
Circ_0025033 promotes the progression of ovarian cancer by activating the expression of LSM4 via targeting miR-18450
Significance of miRNAs on the thyroid cancer progression and resistance to treatment with special attention to the role of cross-talk between signaling pathways50
The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay48
Granular cell tumor a study of 42 cases and systemic review of the literature48
miR-145-5p suppresses proliferation, metastasis and EMT of colorectal cancer by targeting CDCA348
Immunotherapy of gastric cancer: Past, future perspective and challenges47
The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways46
miRNAs as potential game-changers in melanoma: A comprehensive review46
Circular RNAs: New players in thyroid cancer42
miRNAs as potential game-changers in head and neck cancer: Future clinical and medicinal uses42
STAT6: A review of a signaling pathway implicated in various diseases with a special emphasis in its usefulness in pathology41
Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review39
Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer39
miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay39
The interplay of signaling pathways with miRNAs in cholangiocarcinoma pathogenicity and targeted therapy39
miRNAs as potential game-changers in renal cell carcinoma: Future clinical and medicinal uses38
Nanomicellar-curcumin exerts its therapeutic effects via affecting angiogenesis, apoptosis, and T cells in a mouse model of melanoma lung metastasis38
PI3K/Akt/mTOR signaling pathway in cancer stem cells37
Long non-coding RNAs and rheumatoid arthritis: Pathogenesis and clinical implications37
LncRNA signature in colorectal cancer37
The role of miRNAs in laryngeal cancer pathogenesis and therapeutic resistance – A focus on signaling pathways interplay34
Targeting cancer stem cells by melatonin: Effective therapy for cancer treatment33
miR-509–5p promotes colorectal cancer cell ferroptosis by targeting SLC7A1133
The potential role of miRNAs in the pathogenesis of salivary gland cancer – A Focus on signaling pathways interplay33
0.057929992675781